manufacturing news from FiercePharma
NewsMicrobix teams with China on vaccine plant
More evidence that Asia is the place to be these days: Canada's Microbix Biosystems is plotting a $200 million flu vaccine plant in Hunan province. The cooperative deal puts Microbix in partnership Read more...
Mylan to cut 100 in Puerto Rico
Workers in Caguas, Puerto Rico, braced for the axe as Mylan announced it would eliminate 100 of the 500 positions at that manufacturing plant. The generics maker announced back in March that it would Read more...
GSK plant closure begins 5,000 job cuts
Count GlaxoSmithKline's Puerto Rican plant as an early Avandia casualty. The drug maker will close the factory in Cidra, Puerto Rico, and transfer production of the diabetes med (and its cousin Read more...
FDA warns Genzyme on French plant
Clean up your act, Genzyme--or so says the FDA, which found "significant violations" of manufacturing rules at a French plant that produces the company's Thymoglobulin drug for kidney Read more...
Novartis, MIT to overhaul manufacturing
Novartis is teaming up with the Massachusetts Institute of Technology to develop new ways to manufacture drugs. The pharma giant, whose global headquarters for drug research is based in Cambridge Read more...
AstraZeneca: Just a bit of outsourcing
Did we say that? AstraZeneca is now denying any intention of outsourcing all its manufacturing, saying Read more...
AstraZeneca to outsource manufacturing
How many drugs would a drugmaker make if a drugmaker didn't make drugs? More, says AstraZeneca, or at least more profitable ones. The company is planning to outsource its manufacturing--all of Read more...
MedImmune gets green light for FluMist
Head 'em up, move 'em out. MedImmune says it's cleared up its FluMist manufacturing problems, just in time to ship the product for this year's flu season. The FDA had warned the company in May for Read more...
| Press ReleasesPRESS RELEASE: Amgen to postpone indefinitely plans for a manufacturing facility in Ireland AMGEN TO POSTPONE INDEFINITELY ITS PLANS FOR A MANUFACTURING FACILITY IN IRELAND CORK, IRELAND (Oct. 3, 2007) Amgen today announced that following an updated review of its business plans, concurrent Read more... |
Get more manufacturing coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets